210 related articles for article (PubMed ID: 4899083)
1. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
2. [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Chapal J
Diabetologia; 1969 Feb; 5(1):1-10. PubMed ID: 4907149
[No Abstract] [Full Text] [Related]
3. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
4. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
Loubatières A
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
[No Abstract] [Full Text] [Related]
5. [Insulin liberation from the pancreas by sulfonylurea].
Pfaff W; Schöne HH
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
[No Abstract] [Full Text] [Related]
6. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
[No Abstract] [Full Text] [Related]
7. [Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro].
Weinges KF; Biro G; Kettl H; Mitzuno M
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1467-9. PubMed ID: 4899089
[No Abstract] [Full Text] [Related]
8. [Hypoglycemic sulfonamides].
Loubatières AL
Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
[No Abstract] [Full Text] [Related]
9. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
10. [A new particularly active hypoglycemic sulfonamide, HB 419 (glibenclamide)].
Loubatières A; Mariani MM; Alric R; Capal J; Ribes G; de Malbosc H
Diabete; 1968 Sep; ():Suppl:79-86. PubMed ID: 4924253
[No Abstract] [Full Text] [Related]
11. [Experimental study on glibenclamide (HB 419), a new particularly active hypoglycaemic sulphonamide. II. Betacytotrophic action and stimulation of the neogenesis of the islets of Langerhans].
Loubatières A; Mariani MM; Alric R; Ribes G; de Malbosc H; Houareau MH
Diabetologia; 1969 Aug; 5(4):219-27. PubMed ID: 4902718
[No Abstract] [Full Text] [Related]
12. [Effect of blood sugar decreasing sulfonylureas on the in vitro metabolism of glucose and amino acids in the beta-cells of the pancreas in mice].
Hellerström C; Westman S; Stork H; Schmidt FH
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1464-7. PubMed ID: 4899088
[No Abstract] [Full Text] [Related]
13. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
Loubatières A; Mariani MM; Ribes G; Alric R; Agot H
Diabetologia; 1972 Feb; 8(1):29-36. PubMed ID: 4554823
[No Abstract] [Full Text] [Related]
14. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
Loubathières A; Mariani MM; Ribes G; Chapal J
C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
[No Abstract] [Full Text] [Related]
15. Beta-adrenergic stimulation and insulin release in dogs following HB 419.
Sirek OV; Vigas M; Niki A; Niki H; Sirek A
Diabetologia; 1969 Aug; 5(4):207-10. PubMed ID: 4902716
[No Abstract] [Full Text] [Related]
16. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
[No Abstract] [Full Text] [Related]
17. [Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide].
Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
Klin Wochenschr; 1971 Jul; 49(13):769-70. PubMed ID: 4935073
[No Abstract] [Full Text] [Related]
18. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
19. [Light-optic morphological studies on the B-cells of the islets of langerhans after administration of HB 419].
Bänder A; Pfaff W; Schesmer G
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1448-51. PubMed ID: 4899085
[No Abstract] [Full Text] [Related]
20. [Ultrastructure of the B-cells of the rat pancreas after single and repeated administration of HB 419].
Engelbart K; Bähr H; Kief H
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1456-63. PubMed ID: 4899087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
